Cannara Biotech Inc. announced the appointment of Jack Kay as a Director on it's Board, effective immediately. Mr. Kay is generally recognized as one of Canada's leading pharmaceutical executives, having held senior positions in a number of firms, including CEO of Apotex. Mr. Jack Kay, for 35 years, held various roles at Apotex Inc., including Chief Executive Officer, Chief Operating officer, President and Vice Chairman. He has 50 years' experience in pharmaceutical management and sales. Mr. Kay has served on a number of pharmaceutical and biotech boards, including as the Chairman of Helix Biopharma Corp. and Cangene Corp, and a director at Barr Pharmaceuticals Inc.